ICD-10-CM Billable Code

D61.03

Fanconi anemia

Clinical Classification Guidelines

Inclusion Terms

  • Fanconi pancytopenia
  • Fanconi's anemia

Excludes Type 1

  • Fanconi syndrome (E72.0-)

Medical Intelligence & Overview

Fanconi anemia (FA) is a rare, inherited blood disorder characterized by the bone marrow's inability to produce enough blood cells. This condition can lead to a variety of health issues, including anemia, increased risk of infections, and bleeding problems. Although FA is primarily inherited, its effects are often noticeable early in life, sometimes even during childhood. Recognized under the ICD-10 code D61.03, Fanconi anemia requires careful management and monitoring to address its complex symptoms and associated health risks.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting DNA repair mechanisms Inheritance pattern: autosomal recessive or X-linked traits Environmental factors do not directly cause FA but may influence severity in some cases Familial history of blood disorders or related genetic conditions

Key Symptoms: Pale skin and fatigue due to anemia Frequent or prolonged infections resulting from low white blood cell counts Easy bruising and bleeding episodes related to low platelet counts Short stature or abnormal physical features like arm or skin anomalies Skin hyperpigmentation or café-au-lait spots Developmental delays or skeletal abnormalities in some cases Increased risk of developing blood cancers such as leukemia

Diagnostic & Treatment

Diagnosis Path: Diagnosis of Fanconi anemia involves several steps to confirm the condition: - **Blood tests**: Complete blood count (CBC) showing low levels of red blood cells, white blood cells, and platelets - **Chromosome breakage tests**: The most definitive test involves exposing blood cells to specific agents that induce chromosome breaks, with FA cells showing increased breaks - **Bone marrow biopsy**: To assess marrow cellularity and rule out other causes of pancytopenia - **Genetic testing**: Identifies mutations in genes associated with FA - **Physical evaluation**: To observe physical abnormalities or developmental issues

Treatment Protocols: While there is no cure for Fanconi anemia, various treatments can help manage symptoms and prevent complications: - **Blood transfusions**: To treat anemia and maintain adequate blood counts - **Bone marrow transplantation**: The only potential curative treatment, especially with a well-matched donor - **Androgen therapy**: Medications to stimulate blood cell production - **Growth factors**: Such as G-CSF, to boost white blood cell counts - **Regular monitoring**: Ongoing assessment for potential development of blood cancers - **Supportive care**: Infection prevention, dental care, and addressing physical anomalies Research into gene therapy and other novel treatments continues, offering hope for future management strategies.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D61.03 a billable ICD-10 code?
Yes, D61.03 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D61.03?
Clinical documentation must specify the nature of Fanconi anemia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

fanconi anemia